March 12, 2007
How has your company adapted and responded to the changing economic climate in the past five years when so many others companies did not?
In today’s pharmaceutical marketplace it is crucial to keep up with the latest technologies as well as the industry’s constantly evolving regulations. ClinPhone recognizes the importance of globalizing its business in order to succeed, and developing new technologies that will allow clinical trials to become more effective and efficient. Clients looking for more ways to reduce costs and speed time to market are working closely with ClinPhone to incorporate the best clinical trials technology that will benefit them. In addition, ClinPhone is globally expanding its business into new and existing areas in the United States, Europe, Asia Pacific, and Australia.
What is your vision for the future of the life sciences market over the next several years?
Over the next several years, the market will experience increased R&D spending as well as increased outsourcing by pharmaceutical companies. As the technology involved in tracking clinical trials increases, the market should also expect to see a movement to integrate these technologies in an effort to produce improved information and data. Enhanced technology platforms will deliver the ability to reduce time to market and improve the success rate for new compounds. Finally, the market will see personalized medicine become a reality with the improved information.
What products and services does your company provide and what special capabilities do they offer the life sciences market?
As the industry’s first Clinical Technology Organization (CTO), ClinPhone is proud to offer its clients an end-to-end clinical technology solution for the management of all their clinical research projects. ClinPhone offers a range of innovative products to assist in the areas of clinical trials management systems (CTMS), compliance solutions, disease management, drug accountability, eLearning, electronic data capture (EDC), electronic patient reported outcomes (ePRO), integration, patient recruitment, patient registry, randomization, site management, trial supplies management, trials supplies simulation, and provides sponsors and Contract Research Organizations (CRO) with real-time access to patient data.
Partnerships are an effective way to track life science advances and ensure that your company delivers timely products and services. Which life sciences companies or organizations have you partnered with or invested in and why?
ClinPhone has worked with all the major players in the pharmaceutical industry, including all the companies in the top 20. The company has provided services to biotechnology companies, small and medium sized pharmaceuticals, and has worked closely with the industry’s top CROs. ClinPhone has experience in over 1,800 clinical trials, supporting over 90,000 sites, and its solutions are in 88 countries and 71 languages.
What are your most exciting products and initiatives in development, and how will they improve life science research?
The biggest problem sponsors face today is the issue of reliable data integration. ClinPhone’s goal is to build the most advanced eClinical solution that will revolutionize the way clinical trials are conducted and data is managed. An industry first, ClinPhone’s Connect framework provides sponsors with a standards-based integration hub and serves the needs of all enterprise-wide systems while removing integration technology dependencies on the data management solution. Best of all, Connect can be used to integrate any two systems, not just the ClinPhone solution — serving not only ClinPhone’s product interests, but also serving the needs of its valued customers.
Where do you see your company in five years?
ClinPhone will be recognized as the number one Clinical Technology Organization (CTO) in the pharmaceutical industry. The company will be looked to as the number one provider for end-to-end clinical trials solutions as well as industry thought leadership. Finally, ClinPhone will continue to work in partnership with its global customers and other thought leaders to provide the market with the absolute best clinical trials technology.